Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder

Against a background of (a) increased drinking behavior in children with attention-deficit hyperactivity disorder (ADHD); (b) the parallel between some behaviors associated with ADHD and hypertension; (c) the use of the spontaneously hypertensive rat as a model for ADHD; and (d) similarities in the changes of neuropeptide Y (NPY) and catecholamine in studies of hypertension and drinking, NPY, catecholamines and electrolyte balance were compared in the plasma and urine of healthy children and those with ADHD. Drinking was monitored during 3 h of neuropsychological tests over 2 days in 14 ADHD and nine healthy children. Patients drank four times as much water and showed twice the levels of NPY found in controls. In controls there were positive and in patients there were negative relationships for NPY with drinking and restless behavior. Patients' plasma levels of norepinephrine (NE) and epinephrine were slightly elevated, but urinary levels of NE and the serotonin metabolite were markedly increased. Urinary excretion rates for sodium (not potassium), phosphate and especially calcium were decreased in patients even after covarying for less urine production in the ADHD group. NPY levels were inversely related to calcium excretion and drinking was inversely related to circulating sodium. Increases of drinking and circulating NPY in ADHD children and decreased electrolyte excretion may reflect a common disturbance in metabolic homeostasis.

[1]  M. Fregly,et al.  Effect of administration of angiotensin II and isoproterenol, alone and in combination, on drinking and tail skin temperature of the rat , 1995, Pharmacology Biochemistry and Behavior.

[2]  Rémi Quirion,et al.  Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues , 1992, Progress in Neurobiology.

[3]  R. Oades,et al.  A test of conditioned blocking and its development in childhood and adolescence : Relationship to personality and monoamine metabolism , 1996 .

[4]  D. Erlinge,et al.  Neuropeptide Y-like immunoreactivity and hypertension , 1992, Journal of hypertension.

[5]  R. Oades,et al.  Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attention-deficit or tourette/tic symptoms , 1996, Biological Psychology.

[6]  P. Pruszczyk,et al.  Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension. , 1995, Clinical and experimental hypertension.

[7]  W. Rascher,et al.  Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. , 1993, The Journal of pediatrics.

[8]  F. Brucker-Davis,et al.  Thyroid hormones correlate with symptoms of hyperactivity but not inattention in attention deficit hyperactivity disorder , 1997, Psychoneuroendocrinology.

[9]  C. Conners Attention Deficit Disorder: Clinical and Basic Research , 1991 .

[10]  R. Oades Attention deficit disorder with hyperactivity (ADDH): The contribution of catecholaminergic activity , 1987, Progress in Neurobiology.

[11]  F Fazekas,et al.  Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. , 1991, Archives of neurology.

[12]  B. Müller,et al.  The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis , 1997, Behavioural Brain Research.

[13]  D. Trudeau,et al.  Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). , 1967, Clinical chemistry.

[14]  F Xavier Castellanos,et al.  Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder , 1996, Neuropsychopharmacology.

[15]  J. Rapoport,et al.  Thyroid function and attention-deficit hyperactivity disorder. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[16]  M. Javors,et al.  Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  M. Hariharan,et al.  Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys , 1996, Biological Psychiatry.

[18]  B. Leventhal,et al.  Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity , 1995, Psychiatry Research.

[19]  P. J. Graham,et al.  Effects of a few food diet in attention deficit disorder. , 1993, Archives of disease in childhood.

[20]  R. J. Leo,et al.  Utility of thyroid function screening in adolescent psychiatric inpatients. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  K. Fuxe,et al.  Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat , 1991, Brain Research.

[22]  T. O'donohue,et al.  Amphetamine-induced changes in immunoreactive NPY in rat brain, pineal gland and plasma , 1985, Peptides.

[23]  T. Lohmeier,et al.  Blood pressure regulation: basic concepts. , 1981, Federation proceedings.

[24]  W. Rascher,et al.  Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  C. Best Best and Taylor's Physiological basis of medical practice , 1985 .

[26]  M. Campagnole-Santos,et al.  Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors , 1994, Brain Research.

[27]  J. Markowitz,et al.  Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention‐deficit hyperactivity disorder , 1997 .

[28]  J. Egger,et al.  Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome , 1992, The Lancet.

[29]  S. Frankmann,et al.  Differential changes in central monoaminergic metabolism during first and multiple sodium depletions in rats , 1994, Pharmacology Biochemistry and Behavior.

[30]  T. Sagvolden,et al.  Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains , 1993, Physiology & Behavior.

[31]  J. Herbert,et al.  Regional suppression by water intake of c-fos expression induced by intraventricular infusions of angiotensin II , 1994, Brain Research.